Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

PSORI-CM01

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
BACKGROUND Psoriasis is an inflammatory skin disease that affects an estimated 3% of the world's population. PSORI-CM02 is an… Expand
2019
2019
The IL-17-producing CD4+ T cell and γδT cells play critical roles in the pathogenesis of psoriasis (PS). PSORI-CM02 is a… Expand
2019
2019
AIMS Psoriasis is a refractory skin disease characterized by macrophage cell infiltrated in the dermal layer. Macrophages can… Expand
2018
2018
Psoriasis is an autoimmune and inflammatory disease, which is estimated to affect 2–3% of the population in the world. PSORI-CM02… Expand
  • table 2
  • table 3
2017
2017
Paeonol, an active component derived from the traditional Chinese medicine Cortex Moutan, possesses anti-inflammatory, analgesic… Expand
  • figure 1
  • figure 2
  • figure 2
  • figure 3
  • figure 3
2017
2017
Pancreatic ductal adenocarcinoma (PDAC) and colorectal cancer (CRC) are notoriously challenging for treatment. Hyperactive… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
2017
2017
&NA; Psoriasis is a common chronic inflammatory disease in which T‐helper 1(Th1) and T‐helper 17(Th17) cells play an important… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Review
2016
Review
2016
BackgroundTo provide evidence that the Chinese herbal medicine (CHM) PSORI-CM01 combined with Western medicine reduces the… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
2016
2016
BackgroundPsoriasis is a chronically recurrent inflammatory skin disease, modern medicine could achieve good therapeutic effect… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2015
2015
PSORI-CM01 is a Chinese medicine formula prepared from medicinal herbs and used in China for the treatment of psoriasis. However… Expand
  • figure 1
  • table 2
  • table 3
  • table 4
  • figure 2